InspireMD, Inc. (NSPR) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, InspireMD reported revenue of $9.0M, up 28.1% from $7.0M the year before. Net income was -$48.8M (a -543.3% net margin), or -$0.76 per diluted share. Gross margin was 29.5% and operating margin was -552.6%. Operating activities generated -$35.1M of cash, leaving -$36.8M of free cash flow. At fiscal year end, InspireMD held $69.4M in total assets against $14.2M in total liabilities, including $8.9M of cash and equivalents.
Open the full interactive InspireMD financials → Quarterly statements, key ratios, valuation history and price charts.
InspireMD Key Stats
| Share Price | $0.50 |
|---|---|
| Market Cap | $42.3M |
| Revenue YoY Growth | +28.1% |
| 52-Week Range | $0.48 – $2.42 |
| Shares Outstanding | 84.7 million (basic, 2026 Q2) |
InspireMD Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5M | $4.5M | $5.2M | $6.2M | $7.0M | $9.0M |
| Cost of Goods Sold | $2.4M | $3.7M | $4.1M | $4.4M | $5.5M | $6.3M |
| Gross Profit | $83,000 | $754,000 | $1.1M | $1.8M | $1.5M | $2.6M |
| Operating Income | -$10.4M | -$14.7M | -$18.7M | -$21.1M | -$33.5M | -$49.6M |
| Pre-Tax Income | -$10.5M | -$14.9M | -$18.5M | -$19.9M | -$31.9M | -$48.7M |
| Income Tax | $4,000 | $45,000 | $28,000 | $65,000 | $59,000 | $63,000 |
| Net Income | -$10.5M | -$14.9M | -$18.5M | -$19.9M | -$32.0M | -$48.8M |
| Diluted EPS | -$6.90 | -$2.03 | — | -$0.82 | -$0.76 | -$0.76 |
InspireMD Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.5M | $3.1M | $3.4M | $1.8M |
| Net Income | -$12.7M | -$11.8M | -$13.7M | -$14.3M |
| Diluted EPS | -$0.17 | -$0.18 | -$0.16 | -$0.17 |
InspireMD Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.6M | $12.0M | $4.6M | $9.6M | $18.9M | $8.9M |
| Current Assets | $15.3M | $37.1M | $21.3M | $44.2M | $40.5M | $61.5M |
| Total Assets | $17.8M | $39.7M | $24.7M | $47.6M | $46.8M | $69.4M |
| Current Liabilities | $3.7M | $4.3M | $5.1M | $6.0M | $7.7M | $10.7M |
| Total Liabilities | $5.6M | $6.2M | $7.3M | $8.1M | $10.7M | $14.2M |
| Shareholders' Equity | $12.2M | $33.5M | $17.4M | $39.5M | $36.1M | $55.2M |
InspireMD Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$9.1M | -$13.2M | -$15.5M | -$16.4M | -$21.9M | -$35.1M |
| Cash From Investing | -$187,000 | -$22.5M | $8.4M | -$16.1M | $12.6M | -$30.6M |
| Cash From Financing | $16.4M | $35.0M | -$140,000 | $37.5M | $18.5M | $55.6M |
| Free Cash Flow | -$9.2M | -$13.6M | -$16.0M | -$16.8M | -$23.3M | -$36.8M |
Figures from InspireMD's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full InspireMD financials page for every line item.
InspireMD Company Profile
| Ticker | NSPR |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Miami, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001433607 |
Frequently Asked Questions
What was InspireMD's revenue in fiscal 2025?
InspireMD (NSPR) reported revenue of $9.0M for fiscal 2025.
What is InspireMD's annual revenue history?
InspireMD's annual revenue by fiscal year: 2020: $2.5M; 2021: $4.5M; 2022: $5.2M; 2023: $6.2M; 2024: $7.0M; 2025: $9.0M.
What was InspireMD's net income in fiscal 2025?
InspireMD reported net income of -$48.8M for fiscal 2025.
What was InspireMD's earnings per share (EPS) in fiscal 2025?
InspireMD's diluted EPS was -$0.76 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did InspireMD generate in fiscal 2025?
InspireMD generated -$36.8M of free cash flow in fiscal 2025.
What was InspireMD's revenue last quarter?
In its most recent reported quarter (2026 Q2), InspireMD reported revenue of $1.8M.
How many shares of InspireMD are outstanding?
InspireMD reported a weighted average of 84.7 million basic shares outstanding in 2026 Q2.
What is InspireMD's market cap?
Based on its latest closing price, InspireMD (NSPR) has a market capitalization of about $42.3M.
When does InspireMD's fiscal year end?
InspireMD's fiscal year end, as registered with the SEC, is December 31.
Where is InspireMD headquartered?
InspireMD lists its business address in Miami, Florida in its SEC filings.